All News #Library
Quality
MiMedx receives FDA warning letter over Axiofill manufacturing concerns
09 Jan 2024 //
ENDPTS
MiMedx reports US FDA warning letter for Axiofill, shares drop
29 Dec 2023 //
REUTERS

Market Place
Sourcing Support